Douglas Evan Godshall's Net Worth
Douglas Evan Godshall's net worth is estimated to be at least $88,528,714.67 as of 11/09/2024. CoreStreet's estimation of Douglas Evan Godshall's net worth is based on their sale of stock and current holding of stock.
Douglas Evan Godshall is CEO at Shockwave Medical Inc. They have executed at least 27 trades of stock as per SEC Form 4 filings. Their most recent trade was for 10,000 units of SWAV stock on 02/15/2024. Their biggest sale was on 11/17/2020 when they sold 132,145 units of Shockwave Medical Inc stock for $12,551,132.10. They typically trade 4 times per year.
Total value of insider buys:
- $29,750.00
Total value of insider sells:
- $88,498,964.67
Most recent insider trade:
- Feb. 15, 2024
Douglas Evan Godshall's Insider Trading History
Shockwave Medical Inc | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|
Feb. 15, 2024 | CEO | 10,000 | $231.56 | Sell | $2,315,600.00 |
Jan. 16, 2024 | CEO | 10,000 | $217.59 | Sell | $2,175,900.00 |
Jan. 5, 2024 | CEO | 10,000 | $200.05 | Sell | $2,000,500.00 |
Dec. 15, 2023 | CEO | 5,000 | $187.80 | Sell | $939,000.00 |
Nov. 15, 2023 | CEO | 5,000 | $174.08 | Sell | $870,400.00 |
Oct. 16, 2023 | CEO | 10,000 | $200.78 | Sell | $2,007,800.00 |
Sept. 15, 2023 | CEO | 10,000 | $212.86 | Sell | $2,128,600.00 |
Aug. 24, 2023 | CEO | 10,000 | $214.62 | Sell | $2,146,200.00 |
Feb. 21, 2023 | CEO | 30,000 | $187.84 | Sell | $5,635,200.00 |
Nov. 14, 2022 | CEO | 30,000 | $240.81 | Sell | $7,224,300.00 |
Aug. 11, 2022 | CEO | 30,000 | $280.60 | Sell | $8,418,000.00 |
June 6, 2022 | CEO | 7,400 | $177.32 | Sell | $1,312,168.00 |
May 27, 2022 | CEO | 2,600 | $175.06 | Sell | $455,156.00 |
May 13, 2022 | CEO | 5,000 | $150.00 | Sell | $750,000.00 |
May 11, 2022 | CEO | 15,000 | $140.87 | Sell | $2,113,050.00 |
Nov. 18, 2021 | CEO | 45,000 | $207.28 | Sell | $9,327,600.00 |
Aug. 18, 2021 | CEO | 45,000 | $188.08 | Sell | $8,463,600.00 |
May 18, 2021 | CEO | 45,000 | $159.36 | Sell | $7,171,200.00 |
Feb. 18, 2021 | CEO | 45,000 | $121.96 | Sell | $5,488,200.00 |
Nov. 17, 2020 | CEO | 132,145 | $94.98 | Sell | $12,551,132.10 |
Aug. 27, 2020 | CEO | 849 | $60.00 | Sell | $50,940.00 |
Aug. 24, 2020 | CEO | 9,359 | $60.00 | Sell | $561,540.00 |
Aug. 21, 2020 | CEO | 16,750 | $60.02 | Sell | $1,005,335.00 |
Aug. 4, 2020 | CEO | 19,357 | $50.01 | Sell | $968,043.57 |
Feb. 18, 2020 | CEO | 30,000 | $43.23 | Sell | $1,296,900.00 |
Nov. 21, 2019 | CEO | 30,000 | $37.42 | Sell | $1,122,600.00 |
Eyepoint Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
---|---|---|---|---|---|
March 29, 2019 | Director | 17,000 | $1.75 | Buy | $29,750.00 |